Isolation and Characterization of Human Dental Pulp Derived Stem Cells by Using Media Containing Low Human Serum Percentage as Clinical Grade Substitutes for Bovine Serum | PLOS ONE
Immunohistochemical study of p185 HER2 and DF3 in primary breast cancer and correlation with CA-15-3 serum tumor marker
![PDF] (1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis. | Semantic Scholar PDF] (1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c10084190b8b30df76443ea176c0e20d533187b8/3-Table1-1.png)
PDF] (1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis. | Semantic Scholar
![PDF) Prognostic Impact of the Tumor Marker CA 15-3 in Patients With Breast Cancer and Bone Metastases Treated With Palliative Radiotherapy PDF) Prognostic Impact of the Tumor Marker CA 15-3 in Patients With Breast Cancer and Bone Metastases Treated With Palliative Radiotherapy](https://i1.rgstatic.net/publication/312924166_Prognostic_Impact_of_the_Tumor_Marker_CA_15-3_in_Patients_With_Breast_Cancer_and_Bone_Metastases_Treated_With_Palliative_Radiotherapy/links/588f2af4aca272fa50e1969b/largepreview.png)
PDF) Prognostic Impact of the Tumor Marker CA 15-3 in Patients With Breast Cancer and Bone Metastases Treated With Palliative Radiotherapy
Increase in the circulating level of hepatocyte growth factor in breast cancer patients with distant metastases
![PDF) Differential diagnosis of ovarian cancer with tumour markers CA 125, CA 15-3 and TAG 72.3 | Hector Rivera - Academia.edu PDF) Differential diagnosis of ovarian cancer with tumour markers CA 125, CA 15-3 and TAG 72.3 | Hector Rivera - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/49353119/mini_magick20190131-9384-hjzkwg.png?1548993182)
PDF) Differential diagnosis of ovarian cancer with tumour markers CA 125, CA 15-3 and TAG 72.3 | Hector Rivera - Academia.edu
![CA 15-3 is predictive of response and disease recurrence following treatment in locally advanced breast cancer | BMC Cancer | Full Text CA 15-3 is predictive of response and disease recurrence following treatment in locally advanced breast cancer | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-6-220/MediaObjects/12885_2006_Article_572_Fig3_HTML.jpg)
CA 15-3 is predictive of response and disease recurrence following treatment in locally advanced breast cancer | BMC Cancer | Full Text
![Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-6-81/MediaObjects/12885_2006_Article_433_Fig3_HTML.jpg)
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text
![The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management](https://www.futuremedicine.com/cms/10.2217/bmt-2020-0015/asset/images/medium/figure1.gif)
The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management
![CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-14-356/MediaObjects/12885_2013_Article_4542_Fig1_HTML.jpg)
CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text
![Wiener Labs CLIA-1000 Special Chemistry Analyzer (Chemiluminiscence Immunoassay System) - Riverside Medical Supplies, Ltd. Wiener Labs CLIA-1000 Special Chemistry Analyzer (Chemiluminiscence Immunoassay System) - Riverside Medical Supplies, Ltd.](https://www.rsmedic.com/wp-content/uploads/2020/01/CLIA-1000-test-menu.png)